RxDoctor Payments Data

Danielle Arthur

Nurse Practitioner · South Shore, KYNPI 1003477118

Payments from drug & device makers

$1,382in general payments, 2019–2025

Across 75 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$404
  • Lilly USA, LLC$299
  • AstraZeneca$177
  • GSK$105
  • Axsome Therapeutics, Inc.$95
  • Ultragenyx Pharmaceutical Inc.$80
  • plus $222 from 5 others

What the payments were for

  • Food & beverage$1,33797%
  • Education$453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,382 in reported general payments places this provider in the 70th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,094
Medicare patients
31
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide50$63,693
VraylarCariprazine Hcl25$39,295
OzempicSemaglutide26$38,338
EliquisApixaban21$22,451
FarxigaDapagliflozin Propanediol24$19,432
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$18,562
LinzessLinaclotide20$16,480
TrulicityDulaglutide11$14,743
MyrbetriqMirabegron14$12,268
JardianceEmpagliflozin14$12,007
InvokanaCanagliflozin12$6,721
Ventolin HfaAlbuterol Sulfate29$1,611
Levothyroxine Sodium114$1,439
Albuterol Sulfate HfaAlbuterol Sulfate39$805
Gabapentin82$697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$299$78,43561 claims
AbbVieVraylar, Linzess$404$55,77545 claims
Novo NordiskOzempic$50$38,33826 claims
AstraZenecaFarxiga$177$19,43224 claims
GSKTrelegy Ellipta$105$18,56216 claims
Astellas Pharma US IncMyrbetriq$66$12,26814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in South Shore

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →